Institute for Research in Immunology and Cancer, Laboratory of Intracellular Signalling, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada.
1] Institute for Research in Immunology and Cancer, Laboratory of Intracellular Signalling, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada. [2] Department of Pathology and Cell Biology, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada.
Nat Rev Mol Cell Biol. 2015 May;16(5):281-98. doi: 10.1038/nrm3979.
RAF family kinases were among the first oncoproteins to be described more than 30 years ago. They primarily act as signalling relays downstream of RAS, and their close ties to cancer have fuelled a large number of studies. However, we still lack a systems-level understanding of their regulation and mode of action. The recent discovery that the catalytic activity of RAF depends on an allosteric mechanism driven by kinase domain dimerization is providing a vital new piece of information towards a comprehensive model of RAF function. The fact that current RAF inhibitors unexpectedly induce ERK signalling by stimulating RAF dimerization also calls for a deeper structural characterization of this family of kinases.
RAF 家族激酶是 30 多年前首次被描述的致癌蛋白之一。它们主要作为 RAS 下游的信号转导中继,与癌症的密切关系激发了大量的研究。然而,我们仍然缺乏对其调节和作用模式的系统理解。最近发现 RAF 的催化活性依赖于由激酶结构域二聚化驱动的变构机制,这为 RAF 功能的综合模型提供了一个重要的新信息。事实上,目前的 RAF 抑制剂通过刺激 RAF 二聚化意外地诱导 ERK 信号,这也要求对这一家族激酶进行更深入的结构特征分析。